Table 2.

Correlation between FZD6 expression and clinicopathological features of UCB patients

Parameters Total	Group	Total	FZD6 expression		P value
			High	Low
Gender	Male	79 (75%)	56 (53%)	23 (22%)	0.682
	Female	27 (25%)	18 (17%)	9 (8%)
Age (years)	<  60	37 (35%)	25 (24%)	12 (11%)	0.713
	≥ 60	69 (65%)	49 (46%)	20 (19%)
Tumor size (cm)	<  3 cm	42 (40%)	24 (23%)	18 (17%)	0.021 *
	≥ 3 cm	64 (60%)	50 (47%)	14 (13%)
Multiplicity	Single	59 (56%)	40 (38%)	19 (18%)	0.613
	Multiple	47 (44%)	34 (32%)	13 (12%)
Histological grade	L	48 (45%)	26 (25%)	22 (21%)	0.003 **
	H	58 (55%)	48 (45%)	10 (9%)
Tumor stage T	Ta,T1	26 (25%)	11 (10%)	15 (14%)	0.001 **
	T2-T4	80 (75%)	63 (59%)	17 (16%)
Lymph nodes metastasis	NO	92 (87%)	63 (59%)	29 (27%)	0.650
	YES	14 (13%)	11 (10%)	3 (3%)

*P < 0.05; **P < 0.01. P < 0.05 was considered significant (Chi-square test between 2 groups)